Effect of Phosphodiesterase Type 5 Inhibition on Microvascular Coronary Dysfunction in Women: A Women's Ischemia Syndrome Evaluation (WISE) Ancillary Study-Reference-Cited by-同舟云学术

Effect of Phosphodiesterase Type 5 Inhibition on Microvascular Coronary Dysfunction in Women: A Women's Ischemia Syndrome Evaluation (WISE) Ancillary Study

Published:2011-07-21 Issue:8 Volume:34 Page:483-487
ISSN:0160-9289
Container-title:Clinical Cardiology
language:en
Short-container-title:Clin Cardiol

Author:

Denardo Scott J.,Wen Xuerong,Handberg Eileen M.,Bairey Merz C. Noel,Sopko George S.,Cooper-DeHoff Rhonda M.,Pepine Carl J.

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference29 articles.

1. Microvascular angina and the continuing dilemma of chest pain with normal coronary angiograms;Cannon;J Am Coll Cardiol.,2009

2. Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia: results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study;Pepine;J Am Coll Cardiol.,2010

3. Endothelial regulation of coronary microvascular tone under physiological and pathophysiological conditions;Chilian;Eur Heart J.,1993

4. From hypertension to heart failure: role of nitric oxide-mediated endothelial dysfunction and emerging insights from myocardial contrast echocardiography;Lapu-Bula;Am J Cardiol.,2007

5. The Women's Ischemia Syndrome Evaluation (WISE) study: protocol design, methodology and feasibility report;Merz;J Am Coll Cardiol.,1999

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel diagnostic approaches and management of coronary microvascular dysfunction;American Journal of Preventive Cardiology;2024-09

2. Sildenafil’s effectiveness in the primary coronary slow flow phenomenon: a pilot randomised controlled clinical trial;Open Heart;2024-08

3. Coronary microvascular disease in women: epidemiology, mechanisms, evaluation, and treatment;Canadian Journal of Physiology and Pharmacology;2024-05-10

4. Coronary microvascular dysfunction;Microvascular Research;2024-05

5. Targeted Therapies for Microvascular Disease;Cardiology Clinics;2024-02